A biotech company that is working on a non-surgical treatment for back problems has relocated from Austin, Texas, to the University of Kentucky Coldstream Research Campus, according to a news release.
Orthopeutics L.P./Intralink Spine Inc. will receive $408,000 in state funds to match federal research grants. Three employees — including the company's chief scientific officer, who will hold a joint UK faculty appointment in engineering and medicine — have moved to Lexington. Additional high-tech positions are likely to be created as the company begins manufacturing.
Orthopeutics/Intralink Spine is working on "an injectable tissue revitalization reagent for the treatment of degenerative disc disease and related lower back pain," according to the release.
Sign Up and Save
Get six months of free digital access to the Lexington Herald-Leader